On February 8, 2023, RepliCel Life Sciences Inc. closed the transaction. The transaction included participation from one investors.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0428 USD | +4.99% | -.--% | -4.89% |
18/04 | RepliCel Life Sciences Inc. Announces Secured Loan Agreement | CI |
2023 | RepliCel Life Sciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-4.89% | 2.78M | |
+2.63% | 108B | |
+9.76% | 105B | |
-0.32% | 23.46B | |
-12.77% | 21.72B | |
-7.05% | 18.64B | |
-38.55% | 17.45B | |
-6.97% | 17.19B | |
+5.98% | 13.99B | |
+35.39% | 12.53B |
- Stock Market
- Equities
- REPCF Stock
- News RepliCel Life Sciences Inc.
- RepliCel Life Sciences Inc. announced that it has received CAD 0.01225 million in funding